Update in Medical Hepatology Part 2

Ramon Bataller, MD, PhD, Naudia L. Jonassaint, MD, MHS, Shahid M. Malik, MD, and Shari Rogal, MD, MPH, discuss updates in medical hepatology, including COVID, autoimmune and cholestatic liver diseases, and how to effectively treat alcohol-related liver disease.

Educational Objectives 

Upon completion of this activity, participants should be able to:

  • Explain COVID-19 transmission data and the effects of COVID-19 on the liver.
  • Identify unusual COVID-19 outcomes in patients with liver disease.
  • Explain the goal of medical therapy in patients with primary biliary cholangitis.
  • Describe the increased risk of malignancy in patients with primary scerlosing cholangitis.
  • Describe the role of UDCA post LT in patients with primary biliary cholangitis.
  • Describe successful approaches to HCV treatment elimination.

Disclosures:

Drs. Shari Rogal, Shahid Malik, and Naudia Jonassaint have reported no relevant relationships with entities producing health care goods or services.

Dr. Ramon Bataller has financial interests with the following entity or entities producing health care goods or services as indicated below:

Other: Echosens Paid Speaking Engagement - June, 2019

All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.

Release Date: 6/18/2021 | Last Modified On: 6/30/2021 | Expires: 6/30/2022